University Professor Identifies Herbal Treatment for Epilepsy, Mental Illness

Mar 27, 2018 0

A professor of Pharmacology and Toxicology at the Faculty of Pharmaceutical Sciences, Kaduna State University has identified that a plant scientifically known as Ficus Platyphylia, could be used for the management of central nervous system (CNS) disorders.  Ben A. Chindo Said the plant which is popularly known as Gamji in Hausa could also be used to manage epilepsy, depression, insomnia, psychosis, pain, inflammation and gastrointestinal disorders. Prof. Chindo made it known during the second inaugural lecture of KASU tagged “Herbal Medicines: Panaceas or agents of destruction” that Ficus Platyphylia is a deciduous plant found mainly in the savanna regions of the West African coast. ...

Read More

 New Cholesterol drug lowers risk of death, heart attack- Study

Mar 12, 2018 0

A newer cholesterol drug, used with older statin medicines, modestly lowered heart risks and deaths in a big study of heart attack survivors that might persuade insurers to cover the pricey treatment more often. Results on the drug, Praluent (PRALL-yoo-ent), were announced Saturday at an American College of Cardiology conference in Florida. It’s the first time a cholesterol-lowering drug has reduced deaths since statins such as Lipitor and Crestor came out decades ago. “It’s the ultimate outcome; it’s what matters to patients,” said study leader Dr. Philippe Gabriel Steg of Hospital Bichat in Paris. ...

Read More

  HIV antibody effective on monkeys: Study

Mar 6, 2018 0

An experimental HIV antibody tested on a group of monkeys showed to be effective as it suppressed the virus for nearly six months without additional treatment, researchers have found. The findings lend a clue to strategies that attempt to achieve sustained, drug-free viral remission in people living with HIV, the Xinhua reported. The researchers may have targeted the viral reservoir — populations of long-lived, latently infected cells that harbour the virus and that lead to resurgent viral replication when suppressive therapy was stopped, the study noted. “HIV excels at evading the immune system by hiding out in certain immune cells,” said Anthony S. Fauci, Director at the National Institute of Allergy and Infectious Diseases (NIAID) in Maryland, US. ...

Read More

 Novel method may prevent hearing loss in kids by 50%

Sep 14, 2017 0

Researchers have developed a new magnetic delivery method that may prevent by 50 per cent the hearing loss caused as a result of treatment by a widely used chemotherapy drug. Cisplatin is commonly used to treat childhood cancers but can lead to permanent or severe high-frequency hearing loss in nine out of 10 children following treatment.  Steroids can reduce cisplatin-induced hearing loss but they may also reduce the effectiveness of cisplatin’s ability to kill cancer cells. ...

Read More

 Folic acid in pregnancy may cut kids’ autism risk

Sep 11, 2017 0

Mothers who take the recommended amounts of folic acid during pregnancy might reduce the risk of their children developing pesticide-related autism, researchers say. The findings showed that if the mother was taking folic acid during the window around conception, the risk associated with pesticides seemed to be attenuated. ...

Read More

Stroke survivors are at double risk of getting cancer

Sep 8, 2017 0

A study has recently warned that stroke survivors are almost doubly at risk of developing cancer. The findings indicated that nearly 45 percent of cancer diagnoses occurred within the first six months after a stroke diagnosis. “Post-mortem studies have suggested that cancer can develop after a stroke, but the magnitude of this association has not been described,” said lead author Dr Jacobo Rogado from Hospital de La Princesa in Madrid, Spain. ...

Read More

First cancer ‘living drug’ gets go-ahead

Aug 31, 2017 0

The US has approved the first treatment to redesign a patient’s own immune system so it attacks cancer.  The regulator – the US Food and Drug Administration – said its decision was a “historic” moment and medicine was now “entering a new frontier”. The company Novartis is charging $475,000 (£367,000) for the “living drug” therapy, which leaves 83% of people free of a type of blood cancer.  Doctors in the UK said the announcement was an exciting step forward. The living drug is tailor-made to each patient, unlike conventional therapies such as surgery or chemotherapy. ...

Read More